Julia Kozlitina

Nov 30, 2023 | erj.ersjournals.com | David Zhang |Justin M. Oldham |Julia Kozlitina |Nicole Garcia

IntroductionThe interstitial lung diseases (ILDs) are a diverse group of inflammatory and fibrotic disorders that often require pharmacological therapy to mitigate progressive loss of lung function. The initial treatment choice is primarily dictated by the ILD subtype.

Aug 17, 2023 | erj.ersjournals.com | David Zhang |Justin M. Oldham |Julia Kozlitina |Nicole Garcia

Thank you for your interest in spreading the word on European Respiratory Society . NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas.